KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2023 HAEi Regional Conference EMEA

KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2023 HAEi Regional Conference EMEA

KalVista Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, today announced the acceptance of multiple abstracts at the 2023 HAEi Regional Conference EMEA meeting taking place in Munich, Germany, from 1-3 September 2023. The presentations are:

• In Their Own Words – Patient Descriptions of the Earliest Recognition of HAE Attack Onset: Michael E. Manning, Autumn F. Burnette, Sally van Kooten, Markus Heckmann, Sherry Danese, Ledia Goga, Mar Guilarte, Anna Valerieva (presenter only). Results shared as a poster presentation and Q&A
• Recognizing the Importance of Early On-Demand Treatment in the HAE Attack Journey: Douglas H. Jones, Princess Ogbogu, Sally van Kooten, Markus Heckmann, Sherry Danese, Ledia Goga, Markus Magerl (presenter). Results shared as a poster presentation and Q&A

(Source: KalVista Pharmaceuticals Inc)